N-[4-[[5-[1-(2-hydroxy-2-methylpropyl)-4-methylindazol-5-yl]-2,6-naphthyridin-3-yl]amino]phenyl]-1,3,5-trimethylpyrazole-4-sulfonamide
C32H34N8O3S — CID 172600371
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-[[5-[1-(2-hydroxy-2-methylpropyl)-4-methylindazol-5-yl]-2,6-naphthyridin-3-yl]amino]phenyl]-1,3,5-trimethylpyrazole-4-sulfonamide
N-[4-[[5-[1-(2-hydroxy-2-methylpropyl)-4-methylindazol-5-yl]-2,6-naphthyridin-3-yl]amino]phenyl]-1,3,5-trimethylpyrazole-4-sulfonamide (PubChem CID 172600371) has the molecular formula C32H34N8O3S and a molecular weight of 610.74 g/mol. Its IUPAC name is N-[4-[[5-[1-(2-hydroxy-2-methylpropyl)-4-methylindazol-5-yl]-2,6-naphthyridin-3-yl]amino]phenyl]-1,3,5-trimethylpyrazole-4-sulfonamide.
Molecular Properties
| Compound Name | N-[4-[[5-[1-(2-hydroxy-2-methylpropyl)-4-methylindazol-5-yl]-2,6-naphthyridin-3-yl]amino]phenyl]-1,3,5-trimethylpyrazole-4-sulfonamide |
|---|---|
| PubChem CID | 172600371 |
| Molecular Formula | C32H34N8O3S |
| Molecular Weight | 610.74 g/mol |
| Exact Mass | 610.25 |
| IUPAC Name | N-[4-[[5-[1-(2-hydroxy-2-methylpropyl)-4-methylindazol-5-yl]-2,6-naphthyridin-3-yl]amino]phenyl]-1,3,5-trimethylpyrazole-4-sulfonamide |
| SMILES | Cc1nn(C)c(C)c1S(=O)(=O)Nc1ccc(Nc2cc3c(-c4ccc5c(cnn5CC(C)(C)O)c4C)nccc3cn2)cc1 |
| InChI | InChI=1S/C32H34N8O3S/c1-19-25(11-12-28-27(19)17-35-40(28)18-32(4,5)41)30-26-15-29(34-16-22(26)13-14-33-30)36-23-7-9-24(10-8-23)38-44(42,43)31-20(2)37-39(6)21(31)3/h7-17,38,41H,18H2,1-6H3,(H,34,36) |
| InChIKey | BBKBLCUAVTYZMR-UHFFFAOYSA-N |
| XLogP | 5.62 |
| TPSA | 139.85 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 610.74 |
| LogP ≤ 5 | 5.62 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 172600371 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.